|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2008-10-13
|
|
pubmed:abstractText |
The goal of this study was to determine whether azimilide, as compared with placebo, will reduce the number of emergency department (ED) visits and hospitalizations caused by arrhythmias or cardiac events in patients with an implantable cardioverter-defibrillator (ICD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
23
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1076-83
|
|
pubmed:meshHeading |
pubmed-meshheading:18848141-Aged,
pubmed-meshheading:18848141-Anti-Arrhythmia Agents,
pubmed-meshheading:18848141-Arrhythmias, Cardiac,
pubmed-meshheading:18848141-Defibrillators, Implantable,
pubmed-meshheading:18848141-Emergency Service, Hospital,
pubmed-meshheading:18848141-Hospitalization,
pubmed-meshheading:18848141-Humans,
pubmed-meshheading:18848141-Imidazolidines,
pubmed-meshheading:18848141-Middle Aged,
pubmed-meshheading:18848141-Piperazines
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial.
|
|
pubmed:affiliation |
Division of Cardiology, St. Michael's Hospital/University of Toronto, Toronto, Ontario, Canada. dorianp@smh.toronto.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
